Requirement of Vascular Integrin α v β 3 for Angiogenesis
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Angiogenesis depends on the adhesive interactions of vascular cells. The adhesion receptor integrin α v β 3 was identified as a marker of angiogenic vascular tissue. Integrin α v β 3 was expressed on blood vessels in human wound granulation tissue but not in normal skin, and it showed a fourfold increase in expression during angiogenesis on the chick chorioallantoic membrane. In the latter assay, a monoclonal antibody to α v β 3 blocked angiogenesis induced by basic fibroblast growth factor, tumor necrosis factor-α, and human melanoma fragments but had no effect on preexisting vessels. These findings suggest that α v β 3 may be a useful therapeutic target for diseases characterized by neovascularization.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the integrin a v b 3 is expressed on blood vessels in human wound granulation tissue but not in normal skin”
From Interactions between extracellular matrix and growth factors in wound healing (2009) · cites this paper as [61]
In the citing paper
“antibodies against this integrin block angiogenesis induced by FGF and TNF-a without affecting preexisting blood vessels”
From Interactions between extracellular matrix and growth factors in wound healing (2009) · cites this paper as [61]
Citations
Cites
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., & Gasparini, G. (1992) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/84.24.1875 · Cited by 1,775
Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H., & Folkman, J. (1990) · Nature · doi:10.1038/348555a0 · Cited by 1,299
Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α
Leibovich, S. J., Polverini, P. J., Shepard, H. M., Wiseman, D. M., Shively, V., & Nuseir, N. (1987) · Nature · doi:10.1038/329630a0 · Cited by 1,210
Cheresh, D. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.18.6471 · Cited by 561
Self-citationCell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors.
Lawler, J., Weinstein, R., & Hynes, R. O. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.6.2351 · Cited by 474
Adams, J. C., & Watt, F. M. (1990) · Cell · doi:10.1016/0092-8674(90)90175-e · Cited by 448
Gladson, C. L., & Cheresh, D. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115516 · Cited by 417
Self-citationLeavesley, D. I., Schwartz, M. A., Rosenfeld, M., & Cheresh, D. A. (1993) · The Journal of cell biology · doi:10.1083/jcb.121.1.163 · Cited by 391
Self-citationInvolvement of integrin alpha V gene expression in human melanoma tumorigenicity.
Felding-Habermann, B., Mueller, B. M., Romerdahl, C. A., & Cheresh, D. A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115811 · Cited by 378
Self-citation
Research works printed but not linked: 1
- FOLKMAN, J, SEMINARS CANCER BIOL 3: 65 (1992).
Cited by
Items 101–200 of 1,011
Canstatin, a Novel Matrix-derived Inhibitor of Angiogenesis and Tumor Growth
Kamphaus, G. D., Colorado, P. C., Panka, D. J., Hopfer, H., Ramchandran, R., Torre, A., Maeshima, Y., Mier, J. W., Sukhatme, V. P., & Kalluri, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1209 · Cited by 475
Haubner, R., Wester, H. J., Burkhart, F., Senekowitsch–Schmidtke, R., Weber, W., Goodman, S. L., Kessler, H., & Schwaiger, M. (2001) · PubMed · Cited by 471
Angiogenic and HIV-Inhibitory Functions of KSHV-Encoded Chemokines
Boshoff, C., Endo, Y., Collins, P. D., Takeuchi, Y., Reeves, J. D., Schweickart, V. L., Siani, M. A., Sasaki, T., Williams, T. J., Gray, P. W., et al. (1997) · Science · doi:10.1126/science.278.5336.290 · Cited by 469
Dendrimers in Oncology: An Expanding Horizon
Tekade, R. K., Kumar, P. V., & Jain, N. K. (2009) · Chemical Reviews · doi:10.1021/cr068212n · Cited by 466
Cancer Cell Adhesion and Metastasis: Selectins, Integrins, and the Inhibitory Potential of Heparins
Bendas, G., & Borsig, L. (2012) · International Journal of Cell Biology · doi:10.1155/2012/676731 · Cited by 458
Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer
Bellahcène, A., Castronovo, V., Ogbureke, K. U. E., Fisher, L. W., & Fedarko, N. S. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2345 · Cited by 454
Imaging Tumor Angiogenesis With Contrast Ultrasound and Microbubbles Targeted to α v β 3
Ellegala, D. B., Leong-Poi, H., Carpenter, J. E., Klibanov, A. L., Kaul, S., Shaffrey, M. E., Sklenar, J., & Lindner, J. R. (2003) · Circulation · doi:10.1161/01.cir.0000080326.15367.0c · Cited by 454
Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases.
Friedlander, M., Theesfeld, C. L., Sugita, M., Fruttiger, M., Thomas, M. A., Chang, S., & Cheresh, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9764 · Cited by 452
Self-citationDavis, G. E., Bayless, K. J., Davis, M. J., & Meininger, G. A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65020-1 · Cited by 452
Role of Angiogenesis in Cardiovascular Disease: A Critical Appraisal
Khurana, R., Simons, M., Martin, J. F., & Zachary, I. C. (2005) · Circulation · doi:10.1161/circulationaha.105.535294 · Cited by 451
Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy
Niu, G., & Chen, X. (2010) · Current Drug Targets · doi:10.2174/138945010791591395 · Cited by 451
Rüegg, C., Yilmaz, A., Bieler, G., Bamat, J., Chaubert, P., & Lejeune, F. J. (1998) · Nature Medicine · doi:10.1038/nm0498-408 · Cited by 450
Matrix Metalloproteinases Generate Angiostatin: Effects on Neovascularization
Cornelius, L. A., Nehring, L. C., Harding, E., Bolanowski, M., Welgus, H. G., Kobayashi, D. K., Pierce, R. A., & Shapiro, S. D. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6845 · Cited by 444
Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor.
Blair, R. J., Meng, H., Marchese, M. J., Ren, S., Schwartz, L. B., Tonnesen, M. G., & Gruber, B. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119458 · Cited by 439
Winter, P. M., Caruthers, S. D., Kassner, A., Harris, T. D., Chinen, L. K., Allen, J. S., Lacy, E. K., Zhang, H., Robertson, J. D., Wickline, S. A., et al. (2003) · PubMed · Cited by 433
Haubner, R., Finsinger, D., & Kessler, H. (1997) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199713741 · Cited by 430
Gutheil, J. C., Campbell, T. N., Pierce, P. R., Watkins, J. D., Huse, W. D., Bodkin, D., & Cheresh, D. A. (2000) · PubMed · Cited by 430
Self-citationWound repair in the context of extracellular matrix
Gailit, J., & Clark, R. A. F. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90099-x · Cited by 426
Self-citationCationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice.
Thurston, G., McLean, J. W., Rizen, M., Baluk, P., Haskell, A., Murphy, T. J., Hanahan, D., & McDonald, D. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci965 · Cited by 423
A Global Review on Short Peptides: Frontiers and Perspectives
Apostolopoulos, V., Bojarska, J., Chai, T.-T., Elnagdy, S., Kaczmarek, K., Matsoukas, J., New, R., Parang, K., Lopez, O. P., Parhiz, H., et al. (2021) · Molecules · doi:10.3390/molecules26020430 · Cited by 421
Genes that Distinguish Physiological and Pathological Angiogenesis
Seaman, S., Stevens, J., Yang, M. Y., Logsdon, D., Graff-Cherry, C., & St. Croix, B. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.017 · Cited by 419
Bachmann, M., Kukkurainen, S., Hytönen, V. P., & Wehrle-Haller, B. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2018 · Cited by 407
Normal Cutaneous Wound Healing: Clinical Correlation with Cellular and Molecular Events
Baum, C. L., & Arpey, C. J. (2005) · Dermatologic Surgery · doi:10.1097/00042728-200506000-00011 · Cited by 404
Integrin-associated Protein Is a Receptor for the C-terminal Domain of Thrombospondin
Gao, A.-G., Lindberg, F. P., Finn, M. B., Blystone, S. D., Brown, E. J., & Frazier, W. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.1.21 · Cited by 402
Lee, T. T., García, J. R., Paez, J. I., Singh, A., Phelps, E. A., Weis, S., Shafiq, Z., Shekaran, A., del Campo, A., & García, A. J. (2015) · Nature Materials · doi:10.1038/nmat4157 · Cited by 402
Eliceiri, B. P., Klemke, R., Strömblad, S., & Cheresh, D. A. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.5.1255 · Cited by 396
Self-citationPozzi, A., Moberg, P. E., Miles, L. A., Wagner, S., Soloway, P., & Gardner, H. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040378497 · Cited by 395
Integrin and Growth Factor Receptor Crosstalk
Eliceiri, B. P. (2001) · Circulation Research · doi:10.1161/hh2401.101084 · Cited by 395
Retinal and choroidal neovascularization
Campochiaro, P. A. (2000) · Journal of Cellular Physiology · doi:10.1002/1097-4652(200009)184:3<301::aid-jcp3>3.0.co;2-h · Cited by 393
Caswell, P. T., Chan, M., Lindsay, A. J., McCaffrey, M. W., Boettiger, D., & Norman, J. C. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200804140 · Cited by 388
Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
Janssen, M. L., Oyen, W. J. G., Dijkgraaf, I., Massuger, L. F. A. G., Frielink, C., Edwards, D. S., Rajopadhye, M., Boonstra, H., Corstens, F. H. M., & Boerman, O. C. (2002) · PubMed · Cited by 385
Integrins as receptors for laminins
Belkin, A. M., & Stepp, M. A. (2000) · Microscopy Research and Technique · doi:10.1002/1097-0029(20001101)51:3<280::aid-jemt7>3.0.co;2-o · Cited by 384
The role of integrins in inflammation and angiogenesis
Mezu-Ndubuisi, O. J., & Maheshwari, A. (2021) · Pediatric Research · doi:10.1038/s41390-020-01177-9 · Cited by 384
Angiogenesis drives psoriasis pathogenesis
Heidenreich, R., Röcken, M., & Ghoreschi, K. (2009) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2009.00669.x · Cited by 383
Strömblad, S., Becker, J. C., Yebra, M., Brooks, P. C., & Cheresh, D. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118808 · Cited by 383
Self-citationThe ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization
Ogawa, K., Pasqualini, R., Lindberg, R. A., Kain, R., Freeman, A. L., & Pasquale, E. B. (2000) · Oncogene · doi:10.1038/sj.onc.1204004 · Cited by 380
Temperature Triggered Self-Assembly of Polypeptides into Multivalent Spherical Micelles
Dreher, M. R., Simnick, A. J., Fischer, K., Smith, R. J., Patel, A., Schmidt, M., & Chilkoti, A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja0764862 · Cited by 377
Wu, Y., Zhang, X., Xiong, Z., Cheng, Z., Fisher, D. R., Liu, S., Gambhir, S. S., & Chen, X. S. (2005) · PubMed · Cited by 377
Piali, L., Hammel, P., Uherek, C., Bachmann, F., Gisler, R. H., Dunon, D., & Imhof, B. A. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.2.451 · Cited by 376
An integrin β3-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition
Seguin, L., Kato, S., Franovic, A., Camargo, M. F., Lesperance, J., Elliott, K. C., Yebra, M., Mielgo, A., Lowy, A. M., Husain, H., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb2953 · Cited by 374
Self-citationAngiogenesis as a Novel Component of Inflammatory Bowel Disease Pathogenesis
Danese, S., Sans, M., de la Motte, C., Graziani, C., West, G., Phillips, M. H., Pola, R., Rutella, S., Willis, J., Gasbarrini, A., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.054 · Cited by 374
Tumor Cell-Organ Microenvironment Interactions in the Pathogenesis of Cancer Metastasis
Langley, R. R., & Fidler, I. J. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0027 · Cited by 373
Marching at the front and dragging behind
Ballestrem, C., Hinz, B., Imhof, B. A., & Wehrle-Haller, B. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200107107 · Cited by 369
Mathematical modeling of tumor-induced angiogenesis
Mantzaris, N. V., Webb, S., & Othmer, H. G. (2004) · Journal of Mathematical Biology · doi:10.1007/s00285-003-0262-2 · Cited by 362
Koontongkaew, S. (2013) · Journal of Cancer · doi:10.7150/jca.5112 · Cited by 361
Distinct Antitumor Properties of a Type IV Collagen Domain Derived from Basement Membrane
Maeshima, Y., Colorado, P. C., Torre, A., Holthaus, K. A., Grunkemeyer, J. A., Ericksen, M. B., Hopfer, H., Xiao, Y., Stillman, I. E., & Kalluri, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001956200 · Cited by 358
In Vitro Models of Vasculogenesis and Angiogenesis
Vailhé, B., Vittet, D., & Feige, J.-J. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780252 · Cited by 357
Li, M.-L., Oh, J.-T., Xie, X., Ku, G., Wang, W., Li, C., Lungu, G., Stoica, G., & Wang, L. V. (2008) · Proceedings of the IEEE · doi:10.1109/jproc.2007.913515 · Cited by 352
The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia
Klein, G., Vellenga, E., Fraaije, M. W., Kamps, W. A., & de Bont, E. S. J. M. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2003.09.001 · Cited by 350
Role of Osteopontin in Cellular Signaling and Toxicant Injury
Denhardt, D. T., Giachelli, C. M., & Rittling, S. R. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.723 · Cited by 349
Liu, S. (2009) · Bioconjugate Chemistry · doi:10.1021/bc900167c · Cited by 344
Characterization of Human Chorionic Gonadotropin as a Novel Angiogenic Factor
Zygmunt, M., Herr, F., Keller-Schoenwetter, S., Kunzi-Rapp, K., Münstedt, K., Rao, C. V., Lang, U., & Preissner, K. T. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020642 · Cited by 342
αvβ3 and αvβ5 Integrin Expression in Glioma Periphery
Bello, L., Francolini, M., Marthyn, P., Zhang, J., Carroll, R. S., Nikas, D. C., Strasser, J. F., Villani, R., Cheresh, D. A., & Black, P. M. (2001) · Neurosurgery · doi:10.1097/00006123-200108000-00022 · Cited by 341
Self-citationRadiolabeled Multimeric Cyclic RGD Peptides as Integrin αvβ3Targeted Radiotracers for Tumor Imaging
Liu, S. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060049x · Cited by 340
Zhang, C., Jugold, M., Woenne, E. C., Lammers, T., Morgenstern, B., Mueller, M. M., Zentgraf, H., Bock, M., Eisenhut, M., Semmler, W., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1668 · Cited by 336
Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with Paclitaxel
Danhier, F., Vroman, B., Lecouturier, N., Crokart, N., Pourcelle, V., Freichels, H., Jérôme, C., Marchand-Brynaert, J., Feron, O., & Préat, V. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.011 · Cited by 335
Noninvasive Assessment of Angiogenesis by Ultrasound and Microbubbles Targeted to α v -Integrins
Leong-Poi, H., Christiansen, J., Klibanov, A. L., Kaul, S., & Lindner, J. R. (2003) · Circulation · doi:10.1161/01.cir.0000044916.05919.8b · Cited by 334
Emerging roles of ECM remodeling processes in cancer
Mohan, V., Das, A., & Sagi, I. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.09.004 · Cited by 334
Eliceiri, B. P., Puente, X. S., Hood, J. D., Stupack, D. G., Schlaepfer, D. D., Huang, X. Z., Sheppard, D., & Cheresh, D. A. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200109079 · Cited by 333
Self-citationCox, C. M., D'Agostino, S. L., Miller, M. K., Heimark, R. L., & Krieg, P. A. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.04.452 · Cited by 330
Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response
Markowska, A. I., Liu, F.-T., & Panjwani, N. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20090121 · Cited by 330
Iron oxide nanoparticles for targeted cancer imaging and diagnostics
Rosen, J. E., Chan, L., Shieh, D.-B., & Gu, F. X. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.08.017 · Cited by 329
Hammes, H.-P., Brownlee, M., Jonczyk, A., Sutter, A., & Preissner, K. T. (1996) · Nature Medicine · doi:10.1038/nm0596-529 · Cited by 328
Pries, A. R., & Kuebler, W. M. (2006) · Springer eBooks · doi:10.1007/3-540-32967-6_1 · Cited by 328
Drake, C. J., & Little, C. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7657 · Cited by 324
Peptides and Peptide Hormones for Molecular Imaging and Disease Diagnosis
Lee, S., Xie, J., & Chen, X. (2010) · Chemical Reviews · doi:10.1021/cr900361p · Cited by 324
Integrin αvβ3‐targeted cancer therapy
Liu, Z., Wang, F., & Chen, X. (2008) · Drug Development Research · doi:10.1002/ddr.20265 · Cited by 323
Breier, G., Breviario, F., Caveda, L., Berthier, R., Schnurch, H., Gotsch, U., Vestweber, D., Risau, W., & Dejana, E. (1996) · Blood · doi:10.1182/blood.v87.2.630.bloodjournal872630 · Cited by 323
Angiogenesis inhibition: A review
Auerbach, W., & Auerbach, R. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90027-2 · Cited by 321
Role of Endothelial Nitric Oxide Synthase in Endothelial Cell Migration
Murohara, T., Witzenbichler, B., Spyridopoulos, I., Asahara, T., Ding, B., Sullivan, A., Losordo, D. W., & Isner, J. M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.5.1156 · Cited by 320
New Functions for Non-collagenous Domains of Human Collagen Type IV
Petitclerc, E., Boutaud, A., Prestayko, A., Xu, J., Sado, Y., Ninomiya, Y., Sarras, M. P., Hudson, B. G., & Brooks, P. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.8051 · Cited by 315
Self-citationv Integrins in Angiogenesis and Cancer
Weis, S. M., & Cheresh, D. A. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006478 · Cited by 311
Self-citationVascular‐targeting therapies for treatment of malignant disease
Siemann, D. W., Chaplin, D. J., & Horsman, M. R. (2004) · Cancer · doi:10.1002/cncr.20299 · Cited by 310
Peptide-Based Probes for Targeted Molecular Imaging
Lee, S., Xie, J., & Chen, X. (2010) · Biochemistry · doi:10.1021/bi901135x · Cited by 310
Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist
Storgard, C. M., Stupack, D. G., Jonczyk, A., Goodman, S. L., Fox, R. I., & Cheresh, D. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3756 · Cited by 310
Self-citationVasostatin, a Calreticulin Fragment, Inhibits Angiogenesis and Suppresses Tumor Growth
Pike, S. E., Yao, L., Jones, K. D., Cherney, B., Appella, E., Sakaguchi, K., Nakhasi, H., Teruya-Feldstein, J., Wirth, P., Gupta, G., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2349 · Cited by 310
Lee, M. H., Kim, J. Y., Han, J. H., Bhuniya, S., Sessler, J. L., Kang, C., & Kim, J. S. (2012) · Journal of the American Chemical Society · doi:10.1021/ja303998y · Cited by 309
Drake, C. J., Cheresh, D. A., & Little, C. D. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.7.2655 · Cited by 307
Self-citationThe Use of Therapeutic Peptides to Target and to Kill Cancer Cells
J. Boohaker, R., W. Lee, M., Vishnubhotla, P., M. Perez, J. L., & R. Khaled, A. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712801661004 · Cited by 302
Collateral Growth and Angiogenesis Around Cortical Stroke
Wei, L., Erinjeri, J. P., Rovainen, C. M., & Woolsey, T. A. (2001) · Stroke · doi:10.1161/hs0901.094282 · Cited by 301
Fibrosis and diseases of the eye
Friedlander, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31030 · Cited by 299
Vinatier, D., Orazi, G., Cosson, M., & Dufour, P. (2001) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(00)00405-x · Cited by 295
Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia.
Kwon, H. M., Sangiorgi, G., Ritman, E. L., McKenna, C., Holmes, D. R., Schwartz, R. S., & Lerman, A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1568 · Cited by 295
Sieczkiewicz, G. J., Hussain, M., & Kohn, E. C. (2002) · Ovarian Cancer · doi:10.1007/978-1-4757-3587-1_17 · Cited by 295
Stupack, D. G., & Cheresh, D. A. (2004) · Current Topics in Developmental Biology · doi:10.1016/s0070-2153(04)64009-9 · Cited by 295
Self-citationCell Adhesion Molecules in the Development and Progression of Malignant Melanoma
Johnson, J. P. (1999) · Cancer and Metastasis Reviews · doi:10.1023/a:1006304806799 · Cited by 294
Soman, N. R., Baldwin, S. L., Hu, G., Marsh, J. N., Lanza, G. M., Heuser, J. E., Arbeit, J. M., Wickline, S. A., & Schlesinger, P. H. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38842 · Cited by 293
Favier, B., Alam, A., Barron, P., Bonnin, J., Laboudie, P., Fons, P., Mandron, M., Herault, J.-P., Neufeld, G., Savi, P., et al. (2006) · Blood · doi:10.1182/blood-2005-11-4447 · Cited by 292
Cell adhesion and angiogenesis.
Bischoff, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119168 · Cited by 291
Meyer, A., Auernheimer, J., Modlinger, A., & Kessler, H. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777947740 · Cited by 291
Integrin signaling in malignant melanoma
Kuphal, S., Bauer, R., & Bosserhoff, A.-K. (2005) · Cancer and Metastasis Reviews · doi:10.1007/s10555-005-1572-1 · Cited by 289
Wickham, T. J., Segal, D. M., Roelvink, P. W., Carrion, M. E., Lizonova, A., Lee, G. M., & Kovesdi, I. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.6831-6838.1996 · Cited by 288
Regulation of Endothelial Cell Survival and Apoptosis During Angiogenesis
Chavakis, E., & Dimmeler, S. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000017728.55907.a9 · Cited by 285
Wang, Y., & Becker, D. (1997) · Nature Medicine · doi:10.1038/nm0897-887 · Cited by 284
Targeting the Tumor Microenvironment: From Understanding Pathways to Effective Clinical Trials
Fang, H., & DeClerck, Y. A. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0661 · Cited by 284
Beauvais, D. M., Ell, B. J., McWhorter, A. R., & Rapraeger, A. C. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081278 · Cited by 280
Antiangiogenesis Is Produced by Nontoxic Doses of Vinblastine
Vacca, A., Iurlaro, M., Ribatti, D., Minischetti, M., Nico, B., Ria, R., Pellegrino, A., & Dammacco, F. (1999) · Blood · doi:10.1182/blood.v94.12.4143 · Cited by 279
Polyethylene Glycol-Conjugated Copolymers for Plasmid DNA Delivery
Lee, M., & Kim, S. W. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9003-5 · Cited by 277
Ribatti, D., Nico, B., Vacca, A., Roncali, L., Burri, P. H., & Djonov, V. (2001) · The Anatomical Record · doi:10.1002/ar.10021 · Cited by 277
Tumor-specific expression of αvβ3 integrin promotes spontaneous metastasis of breast cancer to bone
Sloan, E. K., Pouliot, N., Stanley, K. L., Chia, J., Moseley, J. M., Hards, D. K., & Anderson, R. L. (2006) · Breast Cancer Research · doi:10.1186/bcr1398 · Cited by 275
Metadata
- Authors
- Brooks, P. C., Clark, R. A. F., & Cheresh, D. A.
- Affiliations
- Scripps Research Institute (US)
- Stony Brook University (US)
- Venue
- Science
- Published
- 1994-04-22
- Volume
- 264
- Issue
- 5158
- Pages
- 569-571
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2029773366
- Cited by
- 3,020
- References
- 22
- Citations by year
- 2026: 22 · 2025: 30 · 2024: 50 · 2023: 36 · 2022: 57 · 2021: 60 · 2020: 54 · 2019: 60 · 2018: 69 · 2017: 62 · 2016: 91 · 2015: 74 · 2014: 102 · 2013: 124 · 2012: 104
- FWCI
- 31.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA-50286, CA-45726, R01CA045726)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- integrin αvβ3, angiogenesis, chorioallantoic membrane, basic fibroblast growth factor, TNF-α, melanoma, monoclonal antibodies, neovascularization, therapeutic target
- MeSH terms
- Animals, Antibodies, Monoclonal, Blood Vessels, Chick Embryo, Granulation Tissue, Humans, Laminin, Melanoma, Neovascularization, Pathologic, Skin, Tumor Necrosis Factor-alpha, von Willebrand Factor, Integrins, Receptors, Cytoadhesin, Fibroblast Growth Factor 2, Receptors, Vitronectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.